Wang Wang

1.2k total citations
20 papers, 947 citations indexed

About

Wang Wang is a scholar working on Pharmacology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Wang Wang has authored 20 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 11 papers in Surgery and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Wang Wang's work include Apelin-related biomedical research (12 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (11 papers) and Nuclear Receptors and Signaling (9 papers). Wang Wang is often cited by papers focused on Apelin-related biomedical research (12 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (11 papers) and Nuclear Receptors and Signaling (9 papers). Wang Wang collaborates with scholars based in Canada, China and France. Wang Wang's co-authors include Gavin Y. Oudit, John C. Vederas, Shaun M. K. McKinnie, Vaibhav B. Patel, Allan G. Murray, Catherine Llorens‐Cortés, Brent A. McLean, Zhen-Zhou Zhang, Jiuchang Zhong and Josef Penninger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Wang Wang

19 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wang Wang Canada 14 585 457 267 190 158 20 947
T. Radecki Poland 19 465 0.8× 890 1.9× 180 0.7× 34 0.2× 312 2.0× 40 1.5k
Ireneusz Piastucki Poland 15 394 0.7× 720 1.6× 88 0.3× 27 0.1× 248 1.6× 20 1.2k
W. McKnight Canada 12 404 0.7× 248 0.5× 66 0.2× 65 0.3× 108 0.7× 14 791
Anna Gębska Poland 14 76 0.1× 124 0.3× 44 0.2× 118 0.6× 216 1.4× 22 655
Huadong Wang China 17 158 0.3× 111 0.2× 34 0.1× 35 0.2× 286 1.8× 36 752
M. Paubert-Braquet France 15 120 0.2× 72 0.2× 58 0.2× 53 0.3× 209 1.3× 31 686
Kentaro Ando Japan 14 41 0.1× 69 0.2× 90 0.3× 359 1.9× 335 2.1× 69 697
Qiaoyan Cai China 20 175 0.3× 23 0.1× 44 0.2× 48 0.3× 469 3.0× 39 884
Jagdish N. Sharma Kuwait 16 130 0.2× 24 0.1× 38 0.1× 142 0.7× 136 0.9× 35 689
Yu-Mi Lim South Korea 13 83 0.1× 220 0.5× 38 0.1× 15 0.1× 310 2.0× 27 842

Countries citing papers authored by Wang Wang

Since Specialization
Citations

This map shows the geographic impact of Wang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Wang more than expected).

Fields of papers citing papers by Wang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Wang. The network helps show where Wang Wang may publish in the future.

Co-authorship network of co-authors of Wang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wang Wang. A scholar is included among the top collaborators of Wang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang Wang. Wang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Wang & M. Kevin Brown. (2023). Photosensitized [4+2]‐ and [2+2]‐Cycloaddition Reactions of N‐Sulfonylimines. Angewandte Chemie. 135(32). 2 indexed citations
3.
Duan, Dong-Xiao, Xiaohui Li, Lin Yang, Wang Wang, & Hongcan Zhu. (2023). Cognitive dysfunction: An important feature of major depressive disorder. 2(1). 1 indexed citations
4.
Fischer, Conrad, Mahmoud Gheblawi, Wang Wang, et al.. (2021). Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators. RSC Medicinal Chemistry. 12(8). 1402–1413. 11 indexed citations
5.
Fang, Xiang, et al.. (2021). A Green Method for the Synthesis of Sulfones from Thioethers. Chinese Journal of Organic Chemistry. 41(1). 412–412. 4 indexed citations
6.
Fischer, Conrad, Tess Lamer, Mahmoud Gheblawi, et al.. (2020). Optimizing PEG-Extended Apelin Analogues as Cardioprotective Drug Leads: Importance of the KFRR Motif and Aromatic Head Group for Improved Physiological Activity. Journal of Medicinal Chemistry. 63(20). 12073–12082. 14 indexed citations
7.
Fischer, Conrad, Tess Lamer, Wang Wang, et al.. (2019). Plasma kallikrein cleaves and inactivates apelin-17: Palmitoyl- and PEG-extended apelin-17 analogs as metabolically stable blood pressure-lowering agents. European Journal of Medicinal Chemistry. 166. 119–124. 38 indexed citations
8.
Wang, Wang, Mengcheng Shen, Conrad Fischer, et al.. (2019). Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs. Proceedings of the National Academy of Sciences. 116(26). 13006–13015. 46 indexed citations
9.
Tang, Huiling, Wang Wang, Ting Li, et al.. (2017). Effects of cultured Cordyceps mycelia polysaccharide A on tumor neurosis factor-α induced hepatocyte injury with mitochondrial abnormality. Carbohydrate Polymers. 163. 43–53. 22 indexed citations
10.
Zhang, Zhen-Zhou, Wang Wang, Haiyan Jin, et al.. (2017). Apelin Is a Negative Regulator of Angiotensin II–Mediated Adverse Myocardial Remodeling and Dysfunction. Hypertension. 70(6). 1165–1175. 91 indexed citations
11.
McKinnie, Shaun M. K., Wang Wang, Conrad Fischer, et al.. (2017). Synthetic Modification within the “RPRL” Region of Apelin Peptides: Impact on Cardiovascular Activity and Stability to Neprilysin and Plasma Degradation. Journal of Medicinal Chemistry. 60(14). 6408–6427. 37 indexed citations
12.
13.
Zhong, Jiuchang, Zhen-Zhou Zhang, Wang Wang, et al.. (2016). Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(8). 1942–1950. 87 indexed citations
14.
Wang, Wang, Yan Wang, Ting Du, et al.. (2016). Bletilla striata polysaccharide inhibits angiotensin II-induced ROS and inflammation via NOX4 and TLR2 pathways. International Journal of Biological Macromolecules. 89. 376–388. 87 indexed citations
15.
McKinnie, Shaun M. K., et al.. (2016). The Metalloprotease Neprilysin Degrades and Inactivates Apelin Peptides. ChemBioChem. 17(16). 1495–1498. 63 indexed citations
16.
Wang, Wang, Shaun M. K. McKinnie, Maikel Farhan, et al.. (2016). Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17. Hypertension. 68(2). 365–377. 146 indexed citations
17.
Wang, Ying, Yan Wang, Dan Liu, et al.. (2015). Cordyceps sinensis polysaccharide inhibits PDGF-BB-induced inflammation and ROS production in human mesangial cells. Carbohydrate Polymers. 125. 135–145. 33 indexed citations
18.
Wang, Wang, Shaun M. K. McKinnie, Vaibhav B. Patel, et al.. (2013). Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues. Journal of the American Heart Association. 2(4). e000249–e000249. 180 indexed citations
19.
Kazemi‐Bajestani, Seyyed Mohammad Reza, Vaibhav B. Patel, Wang Wang, & Gavin Y. Oudit. (2012). Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges. Cardiology Research and Practice. 2012. 1–11. 23 indexed citations
20.
Wang, Wang, Sreedhar Bodiga, Subhash K. Das, et al.. (2011). Role of ACE2 in diastolic and systolic heart failure. Heart Failure Reviews. 17(4-5). 683–691. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Radecki Breakdown of academic impact, for papers by Ireneusz Piastucki Breakdown of academic impact, for papers by W. McKnight Breakdown of academic impact, for papers by Anna Gębska Breakdown of academic impact, for papers by Huadong Wang Breakdown of academic impact, for papers by M. Paubert-Braquet Breakdown of academic impact, for papers by Kentaro Ando Breakdown of academic impact, for papers by Qiaoyan Cai Breakdown of academic impact, for papers by Jagdish N. Sharma Breakdown of academic impact, for papers by Yu-Mi Lim
Rankless by CCL
2026